Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
27.66
-0.11 (-0.40%)
At close: Sep 11, 2026, 4:00 PM EDT
27.89
+0.23 (0.83%)
After-hours: Sep 11, 2026, 4:10 PM EDT

Alamar Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
132.973026.77
Short-Term Investments
117.08-52.59
Cash & Short-Term Investments
250.053079.36
Cash Growth
--62.19%-
Receivables
20.3412.757.32
Inventory
45.4138.4814.41
Prepaid Expenses
15.5813.475.61
Total Current Assets
331.3894.71106.7
Property, Plant & Equipment
49.1636.6335.1
Other Intangible Assets
1.611.992.04
Other Long-Term Assets
8.836.675.67
Total Assets
390.98139.99149.51

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
13.795.876.19
Accrued Expenses
8.7113.697.36
Current Portion of Leases
2.282.11.91
Current Unearned Revenue
2.190.470.58
Other Current Liabilities
0.991.60.56
Total Current Liabilities
27.9623.7316.59
Long-Term Debt
9.959.81-
Long-Term Leases
39.1829.5631.19
Long-Term Unearned Revenue
0.210.32-
Other Long-Term Liabilities
0.820.530.15
Total Liabilities
78.1263.9547.93

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Common Stock
0.0100
Additional Paid-In Capital
516.299.895.39
Retained Earnings
-203.3-168.78-138.96
Comprehensive Income & Other
-0.14-0.070.15
Total Common Equity
312.86-158.95-133.41
Shareholders' Equity
312.8676.04101.59
Total Liabilities & Equity
390.98139.99149.51

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Total Debt
51.4141.4733.1
Net Cash (Debt)
198.65-11.4746.26
Net Cash Growth
---
Net Cash Per Share
8.39-0.993.89
Filing Date Shares Outstanding
69.3912.0511.09
Total Common Shares Outstanding
69.3912.0511.09
Working Capital
303.4270.9890.11
Book Value Per Share
4.51-13.19-12.03
Tangible Book Value
311.25-160.94-135.46
Tangible Book Value Per Share
4.49-13.36-12.21
Machinery
-17.7312.88
Leasehold Improvements
-1.050.15
SEC Filings: 10-K · 10-Q